UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March ~~January 12~~1, 2012

Tibet Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)

British Virgin Islands	001-35038	Not Applicable
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

Room 1701, 17/F

90 Jaffe Rd.

Wanchai, Hong Kong

(Address of Principal Executive Office) (Zip Code)

(852) 9798 5569

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~ITEM~~Item 58.0201. ~~DEPARTURE~~Other ~~OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS~~Events.

~~(b)~~On ~~Effective~~March ~~January 12~~1, 2012, ~~Mr. Taylor Z.~~Tibet ~~Guo~~Pharmaceuticals, ~~resigned~~Inc. as(the “Company”) issued a ~~director~~press release announcing that its Board of Directors (the “Board”) ~~Registrant,~~has received a non-binding letter from its Chairman and ~~the~~Chief ~~Registrant~~Executive ~~accepted~~Officer, Mr. ~~Guo’s~~ ~~resignation.~~Hong Yu (“Mr. ~~Guo’s~~ ~~resignation~~Yu”) ~~from~~dated ~~Board~~March of1, ~~Directors~~2012, pursuant to which Mr. Yu proposes subject to certain conditions to acquire all of the outstanding ~~Registrant~~shares ~~was~~of ~~not~~common stock of the ~~result~~Company ofin ~~any~~cash ~~disagreement~~at ~~with~~$3 per share which represents a premium over the ~~Registrant~~current stock price (the “Proposal”). The Proposal is both non-binding and subject to certain conditions.

~~(c)~~The ~~Effective~~Board ~~January~~has ~~12,~~formed ~~2012,~~a ~~the~~special ~~Registrant~~committee consisting ~~appointed~~solely ~~Ms.~~of ~~Crystal~~independent ~~Hang,~~directors ~~age~~(the ~~40,~~“Special Committee”) to ~~serve~~consider onMr. ~~the Registrant~~Yu’s ~~Board of Directors~~proposal. ~~Ms.~~The ~~Hang~~Board ~~qualifies~~cautions ~~as an independent~~the ~~director~~Company’s ~~pursuant~~shareholders toand ~~NASDAQ~~others ~~Listing~~considering ~~Rule~~trading ~~5605(a)(15).~~in ~~Ms.~~its ~~Hang~~securities ~~will~~that ~~not~~no ~~serve~~decision onhas ~~any~~been ~~board~~made ~~committees~~by ~~initially.~~the ~~Ms.~~Special ~~Hang has no~~Committee ~~relationship~~ with ~~any~~respect ~~other~~to ~~board member or executive officer of~~ the ~~Registrant~~Proposal. ~~From~~There ~~1995~~can ~~through~~be ~~2002,~~no ~~Ms.~~assurance ~~Hang~~that ~~worked~~any indefinitive ~~the finance~~offer ~~department~~will ofbe ~~China Energy Supermarket (Dongguan) Co.~~made, ~~Ltd.~~that ~~From~~any ~~2002~~agreement ~~through~~will ~~2012,~~be ~~Ms. Hang has served as the finance~~executed ~~supervisor~~or ofthat ~~China~~this ~~Energy~~or ~~Supermarket~~any ~~(Guangzhou)~~other ~~Co.,~~transaction ~~Ltd.~~will ~~Both~~be ~~companies~~approved ~~are~~or ~~engaged in retail sales, and neither entity is related to the Registrant~~consummated. ~~Ms.~~A ~~Hang~~copy ~~has not served on any other boards~~ of ~~directors in~~ the ~~last~~press ~~five~~release ~~years.~~is ~~Ms.~~filed ~~Hang~~herewith ~~earned~~as ~~her~~Exhibit ~~bachelor’s degree in accounting from the Hefei Industry University in 1995~~99.1 ~~The~~and ~~Registrant has selected Ms~~99.2 ~~Hang~~ to ~~serve on~~this ~~the~~current ~~board~~report ofon ~~directors~~Form ~~because~~8-K ~~she has extensive fund management~~ and ~~cash flow management experience that the Registrant believes will be beneficial to advising the Registrant. Ms. Hang~~ is ~~not~~incorporated ~~party~~herein toby ~~any transaction required to be disclosed under Regulation S-K, Item 404(a)~~reference.

~~SIGNATURES~~Item 9.01. Financial Statements and Exhibits.

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.~~Exhibits

	Tibet Pharmaceuticals, Inc.
Date: January 18, 2012	By:	/s/ Hong Yu
		Hong Yu
		Chief Executive Officer

99.1 Press Release dated March 1, 2012.

99.2 Proposal Letter from Mr. Yu

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

	Tibet Pharmaceuticals, Inc.


Date: March 1, 2012	By:	/s/ Hong Yu
		Hong Yu Chief Executive Officer

Filing Compare · TIBET PHARMACEUTICALS, INC.